Related Issuers
by Stephen Carter
May 13, 2025 8:10 AM ET
Centrient Holding BV (DSPPHA) EUR600m 144A/Reg S sr sec notes 2-part. B2/B (stable/stable). Via Citi (B&D)/MS jt glocos and jt physical books/ABN AMRO/GS/Jefferies/Muzuho/Rabo/RBC jt books. No reg rights. List ISE. NY law.
- EUR300m sr sec fixed-rate notes due May 2030 (5y). NC2 (MWC B+50bp) (50%,25%,par). Equity claw: 2y 40%. Special call: 10% per year the 1st 2 years at 103. CoC at 101. IPT: mid-to-high 7s. Price talk: 7.25%-7.50%.
- EUR300m sr sec FRN due May 2030 (5y). NC1 (MWC B+50bp) (then at par). CoC at 101. IPT: E+475bp at 98.50-99.00. Price talk: E+475bp at 99.00-99.50.
Roadshow (small group meetings) 05/12-13 (investor call at 11am UKT 05/12). Books close at 3pm UKT 05/13. Pricing 05/13 UK afternoon. UOP: refinance its EUR515m 1st lien term loan B due 2027 and EUR83m 2nd lien term loan due 2028. Equity sponsor: Bain. Biz: B2B pharma developer and manufacturer of intermediates, active pharmaceutical ingredients (APIs) and finished dosage forms. HQ: Rotterdam, Netherlands.
Netroadshow link: https://www.netroadshow.com/ev...;confId=82536